These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1644189)

  • 41. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning, functional expression and role in cell growth regulation of a hamster 5-HT2 receptor subtype.
    Van Obberghen-Schilling E; Vouret-Craviari V; Haslam RJ; Chambard JC; Pouysségur J
    Mol Endocrinol; 1991 Jul; 5(7):881-9. PubMed ID: 1944295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
    Ruat M; Traiffort E; Leurs R; Tardivel-Lacombe J; Diaz J; Arrang JM; Schwartz JC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8547-51. PubMed ID: 8397408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors.
    Parker EM; Grisel DA; Iben LG; Shapiro RA
    J Neurochem; 1993 Jan; 60(1):380-3. PubMed ID: 8417162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
    Kursar JD; Nelson DL; Wainscott DB; Baez M
    Mol Pharmacol; 1994 Aug; 46(2):227-34. PubMed ID: 8078486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conversion of the human 5-HT1D beta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis.
    Metcalf MA; McGuffin RW; Hamblin MW
    Biochem Pharmacol; 1992 Nov; 44(10):1917-20. PubMed ID: 1449511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
    Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
    Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
    Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP
    Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
    Adham N; Romanienko P; Hartig P; Weinshank RL; Branchek T
    Mol Pharmacol; 1992 Jan; 41(1):1-7. PubMed ID: 1732716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
    Glennon RA; Raghupathi R; Bartyzel P; Teitler M; Leonhardt S
    J Med Chem; 1992 Feb; 35(4):734-40. PubMed ID: 1542100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells.
    Du YL; Wilcox BD; Teitler M; Jeffrey JJ
    Mol Pharmacol; 1994 Jun; 45(6):1125-31. PubMed ID: 8022406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
    Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
    Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
    Choudhary MS; Sachs N; Uluer A; Glennon RA; Westkaemper RB; Roth BL
    Mol Pharmacol; 1995 Mar; 47(3):450-7. PubMed ID: 7700242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.
    Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR
    Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cloning and characterisation of the human 5-HT5A serotonin receptor.
    Rees S; den Daas I; Foord S; Goodson S; Bull D; Kilpatrick G; Lee M
    FEBS Lett; 1994 Dec; 355(3):242-6. PubMed ID: 7988681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
    Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
    Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
    Veldman SA; Bienkowski MJ
    Mol Pharmacol; 1992 Sep; 42(3):439-44. PubMed ID: 1328844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
    Harhammer R; Schäfer U; Ott T
    Arzneimittelforschung; 1992 Oct; 42(10):1175-9. PubMed ID: 1472137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.